NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis $3.60 +0.10 (+2.71%) As of 03:56 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Clover Health Investments Stock (NASDAQ:CLOV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CLOV alerts:Sign Up Key Stats Today's Range$3.48▼$3.6450-Day Range$1.70▼$3.5552-Week Range$1.58▼$3.92Volume4.98 million shsAverage Volume6.18 million shsMarket Capitalization$1.89 billionP/E RatioN/ADividend YieldN/APrice Target$2.90Consensus RatingHold Company Overview Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members. At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams. This platform flags gaps in care, offers evidence-based treatment suggestions and facilitates member outreach to ensure adherence to preventive screenings and chronic condition management. Clover’s insurance products cover hospitalization, outpatient care, prescription drug benefits and various supplemental services, including telehealth and transportation assistance. Founded in 2014 by Vivek Garipalli and Kris Gale and headquartered in Jersey City, New Jersey, Clover Health has expanded its Medicare Advantage footprint across several U.S. states. The company serves beneficiaries in urban and rural markets, with operations spanning regions such as the Northeast, Southeast and Midwest. Under the leadership of its co-founders, Clover continues to invest in data science, artificial intelligence and member engagement tools to drive clinical quality improvements and cost efficiencies throughout its network.AI Generated. May Contain Errors. Read More Clover Health Investments Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreCLOV MarketRank™: Clover Health Investments scored higher than 23% of companies evaluated by MarketBeat, and ranked 778th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingHold Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.Downside RiskClover Health Investments has a consensus price target of $2.90, representing about 19.3% downside from its current price of $3.60.Amount of Analyst CoverageClover Health Investments has only been the subject of 3 research reports in the past 90 days.Read more about Clover Health Investments' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Clover Health Investments are expected to remain at ($0.02) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -29.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -29.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 5.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Clover Health Investments' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.74% of the float of Clover Health Investments has been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 3.68%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.16 News SentimentClover Health Investments has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Clover Health Investments this week, compared to 5 articles on an average week.Search Interest45 people have searched for CLOV on MarketBeat in the last 30 days. This is an increase of 165% compared to the previous 30 days.MarketBeat Follows3 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $954,534.00 in company stock.Percentage Held by Insiders23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Stock News HeadlinesClover Health's Bullish Setup Still Looks CompellingMay 20 at 10:00 AM | seekingalpha.comCarladenise Armbrister Edwards Sells 67,160 Shares of Clover Health Investments (NASDAQ:CLOV) StockMay 20 at 6:33 AM | insidertrades.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 20 at 1:00 AM | Porter & Company (Ad)Clover Health Investments, Corp. (NASDAQ:CLOV) Given Average Rating of "Hold" by BrokeragesMay 16, 2026 | americanbankingnews.comClover Health Investments (NASDAQ:CLOV) CEO Sells $345,097.28 in StockMay 15, 2026 | insidertrades.comClover Health Earnings Call Signals Profitable GrowthMay 15, 2026 | theglobeandmail.comA Look At Clover Health (CLOV) Valuation After Profitability Return And Medicare Advantage GrowthMay 9, 2026 | finance.yahoo.comClover Health Investments, Corp. Q1 2026 Earnings Call SummaryMay 8, 2026 | finance.yahoo.comSee More Headlines CLOV Stock Analysis - Frequently Asked Questions How have CLOV shares performed this year? Clover Health Investments' stock was trading at $2.35 at the beginning of the year. Since then, CLOV stock has increased by 52.1% and is now trading at $3.5750. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by $0.02. The company had revenue of $749.19 million for the quarter, compared to the consensus estimate of $714.89 million. Clover Health Investments had a negative net margin of 2.58% and a negative trailing twelve-month return on equity of 16.52%. Read the conference call transcript. Who are Clover Health Investments' major shareholders? Top institutional investors of Clover Health Investments include Dimensional Fund Advisors LP (0.65%), Renaissance Technologies LLC (0.65%), Bank of New York Mellon Corp (0.22%) and California State Teachers Retirement System (0.09%). Insiders that own company stock include Brady Patrick Priest, Conrad Wai, Karen Soares, Carladenise Armbrister Edwards and Anna U Loengard. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Clover Health Investments own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA). Company Calendar Last Earnings5/06/2026Today5/20/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, CLOV's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryInsurance Current SymbolNASDAQ:CLOV CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees680Year Founded2014Price Target and Rating Average Price Target for Clover Health Investments$2.90 High Price Target$3.20 Low Price Target$2.50 Potential Upside/Downside-18.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$85.55 million Net Margins-2.58% Pretax Margin-2.58% Return on Equity-16.52% Return on Assets-9.28% Debt Debt-to-Equity RatioN/A Current Ratio1.33 Quick Ratio1.33 Sales & Book Value Annual Sales$1.92 billion Price / Sales0.98 Cash FlowN/A Price / Cash FlowN/A Book Value$0.64 per share Price / Book5.59Miscellaneous Outstanding Shares526,680,000Free Float402,861,000Market Cap$1.88 billion OptionableOptionable Beta2.44 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:CLOV) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump is positioned. Elon lights the fuse.Bitcoin is sliding. Sentiment is collapsing. And retail investors are once again convinced the market is heade...Crypto 101 Media | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredLAST CALL for SpaceX (IPO Imminent)Bloomberg values the SpaceX IPO at $1.75 trillion - CNBC has called it potentially the biggest IPO ever, and B...Tim Sykes | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
